FI862124L - Morfinderivat. - Google Patents

Morfinderivat. Download PDF

Info

Publication number
FI862124L
FI862124L FI862124A FI862124A FI862124L FI 862124 L FI862124 L FI 862124L FI 862124 A FI862124 A FI 862124A FI 862124 A FI862124 A FI 862124A FI 862124 L FI862124 L FI 862124L
Authority
FI
Finland
Prior art keywords
morfinders
Prior art date
Application number
FI862124A
Other languages
English (en)
Finnish (fi)
Other versions
FI862124A0 (fi
FI862124A7 (fi
Inventor
Laszlo Revesz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI862124A0 publication Critical patent/FI862124A0/fi
Publication of FI862124L publication Critical patent/FI862124L/fi
Publication of FI862124A7 publication Critical patent/FI862124A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI862124A 1985-05-23 1986-05-21 Morfiinijohdannaisia. FI862124A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3518525 1985-05-23

Publications (3)

Publication Number Publication Date
FI862124A0 FI862124A0 (fi) 1986-05-21
FI862124L true FI862124L (fi) 1986-11-24
FI862124A7 FI862124A7 (fi) 1986-11-24

Family

ID=6271435

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862124A FI862124A7 (fi) 1985-05-23 1986-05-21 Morfiinijohdannaisia.

Country Status (18)

Country Link
JP (1) JPS61271275A (fr)
AU (1) AU594954B2 (fr)
BE (1) BE904796A (fr)
DK (1) DK240386A (fr)
ES (1) ES8802318A1 (fr)
FI (1) FI862124A7 (fr)
FR (1) FR2582309B1 (fr)
GB (1) GB2175898B (fr)
GR (1) GR861318B (fr)
HU (1) HU196376B (fr)
IL (1) IL78872A0 (fr)
IT (1) IT1203791B (fr)
LU (1) LU86435A1 (fr)
NL (1) NL8601188A (fr)
NZ (1) NZ216250A (fr)
PH (1) PH23341A (fr)
SE (1) SE8602308L (fr)
ZA (1) ZA863873B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases
US4863928A (en) * 1989-01-04 1989-09-05 Baker Cummins Pharmaceuticals, Inc. Method of treatment for arthritic and inflammatory diseases
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
JP2906654B2 (ja) * 1989-11-28 1999-06-21 東レ株式会社 免疫抑制剤及びその製造方法
US5057322A (en) * 1990-08-10 1991-10-15 Baker Cummins Dermatologicals, Inc. Method of treating mast cell disease
WO1993015081A1 (fr) 1992-01-23 1993-08-05 Toray Industries, Inc. Derive de morphinane et utilisation en medicine
CA2144770C (fr) * 1993-07-19 2006-02-28 Hiroshi Nagase Agent protecteur des neurones
WO1995003308A1 (fr) * 1993-07-23 1995-02-02 Toray Industries, Inc. Derive de morphinane et application medicale
AU706370B2 (en) 1996-01-10 1999-06-17 Smithkline Beecham Spa Heterocycle-condensed morphinoid derivatives (II)
ES2285733T3 (es) * 1996-11-25 2007-11-16 Toray Industries, Inc. Agente antipruritico.
WO1999005146A1 (fr) * 1997-07-25 1999-02-04 Toray Industries, Inc. Remedes contre l'hyponatremie
MXPA04011327A (es) 2002-05-17 2005-08-15 Jenken Biosciences Inc Opioides y compuestos similares a opioides y usos de los mismos.
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP4957489B2 (ja) * 2002-10-09 2012-06-20 東レ株式会社 含窒素環状置換基を有するモルヒナン誘導体またはその薬理学的に許容される酸付加塩を含有する医薬
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP2011512360A (ja) * 2008-02-14 2011-04-21 アルカーメス，インコーポレイテッド 選択的オピオイド化合物
US8987287B2 (en) * 2012-12-14 2015-03-24 Purdue Pharma L.P. Spirocyclic morphinans and their use
US8980906B2 (en) * 2012-12-14 2015-03-17 Purdue Pharma L.P. Pyridonemorphinan analogs and biological activity on opioid receptors
AR096851A1 (es) * 2013-07-11 2016-02-03 H Lundbeck As Sales que no forman hidratos ni solvatos de nalmefeno
JP6360915B2 (ja) * 2014-06-13 2018-07-18 パーデュー、ファーマ、リミテッド、パートナーシップ アザモルフィナン誘導体及びその使用

Also Published As

Publication number Publication date
ES555200A0 (es) 1988-05-01
SE8602308L (sv) 1986-11-24
BE904796A (fr) 1986-11-21
GB2175898B (en) 1989-07-05
AU594954B2 (en) 1990-03-22
IL78872A0 (en) 1986-09-30
HU196376B (en) 1988-11-28
NZ216250A (en) 1990-04-26
IT1203791B (it) 1989-02-23
NL8601188A (nl) 1986-12-16
GB2175898A (en) 1986-12-10
FR2582309A1 (fr) 1986-11-28
SE8602308D0 (sv) 1986-05-21
ES8802318A1 (es) 1988-05-01
JPS61271275A (ja) 1986-12-01
ZA863873B (en) 1988-01-27
FI862124A0 (fi) 1986-05-21
PH23341A (en) 1989-07-14
GR861318B (en) 1986-09-19
LU86435A1 (fr) 1986-12-05
GB8612159D0 (en) 1986-06-25
IT8648050A0 (it) 1986-05-23
HUT41737A (en) 1987-05-28
FI862124A7 (fi) 1986-11-24
DK240386A (da) 1986-11-24
FR2582309B1 (fr) 1989-08-18
AU5763786A (en) 1986-11-27
DK240386D0 (da) 1986-05-22

Similar Documents

Publication Publication Date Title
DE3677710D1 (de) Cefuroximaxetil-dragee.
FI862124L (fi) Morfinderivat.
DE3676026D1 (de) Terpolymerisate.
DE3669772D1 (de) Russblaeser.
DE3688642D1 (de) Fdm-tdm-transmultiplexer.
DE3680574D1 (de) L-aminoacylasen.
DE3686729D1 (de) Aminoalkylpyridinamide.
FI850983A0 (fi) Bipolaer ackumulator.
FI851079L (fi) Kausticeringsfoerfarande.
DE3681550D1 (de) 3-perfluoralkyl-5-hydroxy-isoxazole.
DE3673746D1 (de) Pudermine.
FI850110A0 (fi) Laett snoefordon.
FI850707L (fi) Borrutrustning avsedd foer slaoende borrning.
FI851252L (fi) Transportmedel.
FI73514B (fi) Hoegtrycksinluftsanordning.
FI851829L (fi) Varmluftsutvecklare.
FI851027L (fi) Kalciumsulfatuppslamning.
FI850060A0 (fi) Baeranordning.
FI851892A0 (fi) Tillaeggsanordning foer en snoeskoter.
FI850809L (fi) Elektromekaniskt spaerrskivecylinderlaos.
FI850024L (fi) Kugghjulmotorens specialanvaendningar.
FI850784L (fi) Utraetningsanordning.
FI850624A0 (fi) Slipmaskinsvals.
FI850819A0 (fi) Bollventil.
FI850610A0 (fi) Elastisk utbredningsmatta foer en utbredningsanordning foer skinn.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SANDOZ AG